Migraine medication rimegepant tested in Real-World study
NCT ID NCT06221267
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This study looked at how well the migraine medication rimegepant works in real-life settings. Researchers followed 120 migraine patients in the Greater Bay Area to measure their satisfaction, quality of life, and daily functioning. The goal was to see if rimegepant helps people manage their migraines better outside of a controlled lab environment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, 510120, China
Conditions
Explore the condition pages connected to this study.